These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1660943)

  • 1. [Mode of actions and mechanisms of resistance of new quinolones in Pseudomonas aeruginosa].
    Hirai K; Hashimoto H
    Nihon Rinsho; 1991 Oct; 49(10):2261-5. PubMed ID: 1660943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
    Shen JL; Zhu DM; Wang MG
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential mechanisms of resistance to the modern fluorinated 4-quinolones.
    Lewin CS; Allen RA; Amyes SG
    J Med Microbiol; 1990 Mar; 31(3):153-62. PubMed ID: 2156074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms for the development of quinolone resistance].
    Kojima M
    Nihon Rinsho; 1997 May; 55(5):1252-60. PubMed ID: 9155183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of bacterial resistance to quinolones].
    Yoshida H
    Nihon Saikingaku Zasshi; 1996 Oct; 51(4):973-92. PubMed ID: 8994343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of susceptibility and resistance of Pseudomonas aeruginosa to aminoglycosides].
    Iyobe S
    Nihon Rinsho; 1991 Oct; 49(10):2249-53. PubMed ID: 1749079
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multi-drug resistant Pseudomonas aeruginosa infection].
    Tomono K; Sawai T; Kohno S
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):198-201. PubMed ID: 10088373
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.
    Inoue Y; Sato K; Fujii T; Hirai K; Inoue M; Iyobe S; Mitsuhashi S
    J Bacteriol; 1987 May; 169(5):2322-5. PubMed ID: 3032915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones.
    Okazaki T; Hirai K
    FEMS Microbiol Lett; 1992 Oct; 76(1-2):197-202. PubMed ID: 1330820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones].
    Matsumoto F; Nishiwaki K; Morita M
    Nihon Rinsho; 1991 Oct; 49(10):2291-8. PubMed ID: 1660945
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of action and resistance of older and newer fluoroquinolones.
    Hooper DC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].
    Vila J; Marco F
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):726-36. PubMed ID: 20579775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.
    Reck F; Ehmann DE; Dougherty TJ; Newman JV; Hopkins S; Stone G; Agrawal N; Ciaccio P; McNulty J; Barthlow H; O'Donnell J; Goteti K; Breen J; Comita-Prevoir J; Cornebise M; Cronin M; Eyermann CJ; Geng B; Carr GR; Pandarinathan L; Tang X; Cottone A; Zhao L; Bezdenejnih-Snyder N
    Bioorg Med Chem; 2014 Oct; 22(19):5392-409. PubMed ID: 25155913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of DNA helicases in chromate resistance by Pseudomonas aeruginosa PAO1.
    Miranda AT; González MV; González G; Vargas E; Campos-García J; Cervantes C
    Mutat Res; 2005 Oct; 578(1-2):202-9. PubMed ID: 16105671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa.
    Nakae T
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326
    [No Abstract]   [Full Text] [Related]  

  • 20. Modifications of DNA-gyrase and of permeability in a norfloxacin-resistant clinical isolate of Providencia stuartii.
    Landini P; Pagani L; Debiaggi L; Cereda PM; Romero E
    Microbiologica; 1987 Oct; 10(4):403-11. PubMed ID: 2826973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.